Literature DB >> 17438031

Memory CD4 T cells enhance primary CD8 T-cell responses.

Connie M Krawczyk1, Hao Shen, Edward J Pearce.   

Abstract

CD4 T-cell help is required for optimal memory CD8 T-cell responses. We have found that engaging preexisting CD4 Th1, but not Th2, memory cells at the time of CD8 T-cell priming results in increased CD8 effector responses to both bacterial and viral pathogens. The enhanced responses are characterized by increased numbers of cytokine-producing, antigen-specific cells. These findings suggest that engaging endogenous memory Th1 cells may increase cellular responses in an immunotherapy or vaccination setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438031      PMCID: PMC1932926          DOI: 10.1128/IAI.00086-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses.

Authors:  Kathryn E Foulds; Lauren A Zenewicz; Devon J Shedlock; Jiu Jiang; Amy E Troy; Hao Shen
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

2.  Cutting edge: polarized Th cell response induction by transferred antigen-pulsed dendritic cells is dependent on IL-4 or IL-12 production by recipient cells.

Authors:  Andrew S MacDonald; Edward J Pearce
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

Review 4.  Dendritic-cell control of pathogen-driven T-cell polarization.

Authors:  Martien L Kapsenberg
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

5.  Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo.

Authors:  Jyh-Chiang E Wang; Alexandra M Livingstone
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

6.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

7.  A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.

Authors:  Christine Bourgeois; Benedita Rocha; Corinne Tanchot
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

8.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

Authors:  Joseph C Sun; Matthew A Williams; Michael J Bevan
Journal:  Nat Immunol       Date:  2004-08-08       Impact factor: 25.606

Review 10.  Adenoviruses as vaccine vectors.

Authors:  Nia Tatsis; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2004-10       Impact factor: 11.454

View more
  20 in total

Review 1.  The potential of CD4 T-cell memory.

Authors:  K Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

2.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 3.  Memory CD4 T cells: generation, reactivation and re-assignment.

Authors:  Megan K L MacLeod; John W Kappler; Philippa Marrack
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

4.  The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.

Authors:  Curtis J Henry; Jason M Grayson; Kristina L Brzoza-Lewis; Latoya M Mitchell; Marlena M Westcott; Anne S Cook; Elizabeth M Hiltbold
Journal:  Cell Immunol       Date:  2010-04-24       Impact factor: 4.868

5.  Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.

Authors:  C M Hennies; R A Reboulet; Z Garcia; S Nierkens; M C Wolkers; E M Janssen
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 6.  Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Authors:  Jonathan D Katz; Edith M Janssen
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

7.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection.

Authors:  Kai Dai; Ling Huang; Jing Chen; Lihua Yang; Zuojiong Gong
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

8.  Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.

Authors:  Brenda Raud; Dominic G Roy; Ajit S Divakaruni; Tatyana N Tarasenko; Raimo Franke; Eric H Ma; Bozena Samborska; Wei Yuan Hsieh; Alison H Wong; Philipp Stüve; Catharina Arnold-Schrauf; Melanie Guderian; Matthias Lochner; Shakuntala Rampertaap; Kimberly Romito; Joseph Monsale; Mark Brönstrup; Steven J Bensinger; Anne N Murphy; Peter J McGuire; Russell G Jones; Tim Sparwasser; Luciana Berod
Journal:  Cell Metab       Date:  2018-06-28       Impact factor: 27.287

9.  Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.

Authors:  Maria Bettini; Kristen Rosenthal; Brian D Evavold
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

Review 10.  CD4 memory T cells: what are they and what can they do?

Authors:  Megan K L MacLeod; Eric T Clambey; John W Kappler; Philippa Marrack
Journal:  Semin Immunol       Date:  2009-03-09       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.